Navigation Links
Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results
Date:11/12/2007

SEATTLE, Nov. 12 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) announced today financial results for its third quarter and nine months ended Sept. 30, 2007.

Third Quarter and Nine Months Financial Results

Revenue for the third quarter and nine months ended Sept. 30, 2007, was $4.6 million and $14.5 million, respectively, compared with $16.5 million and $30.2 million, respectively, in 2006. The three- and nine-month decreases were due to decreased milestone revenue, reduced reimbursement revenue from the Wyeth collaboration as a result of the successful transfer of manufacturing activities for TRU-015 from Trubion to Wyeth during 2007, and decreased revenue from the recognition of the $40 million up-front fee from Wyeth due to a change in the estimated research and development service period. These decreases were partially offset by an increase in reimbursable clinical costs related to Trubion's Phase IIb clinical trial for TRU-015 completed in July 2007.

Total operating expenses for the third quarter and nine months ended Sept. 30, 2007, were $11.5 million and $35.9 million, respectively, compared with $11.6 million and $30.6 million, respectively, in 2006. The three-month decrease was primarily due to a decrease in outside manufacturing costs for TRU-015 due to the successful transfer of manufacturing activities to Wyeth during 2007. This decrease was partially offset by increased clinical costs related to our Phase IIb clinical trial for TRU-015, increased personnel- related expenses due to increased headcount and increased outside manufacturing costs related to our TRU-016 product candidate.

The nine-month increase was primarily due to increased clinical costs related
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
2. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Scientists at USC have developed a new microscopy ... in living animals at higher-than-ever resolution. , Dubbed ... allows imaging resolutions that are an order of ... insights into the behavior of biomolecules at the ... Sept. 18 by Nature Communications , the ...
(Date:9/18/2014)... Silicon-valley Electronic Data Capture (EDC) provider ... , the latest addition to Clinovo’s CRO Partnership Program. ... (CRO) Program, Clinovo further expands its global reach to ... training, we are now able to build studies on ... can also rely on Clinovo to fully support the ...
(Date:9/18/2014)... New York, NY (PRWEB) September 18, 2014 ... has completed negotiations with Salem Realty Group and has ... and development space within the Salem Executive Complex adjacent ... cutting ceremony was held on Friday September 5th. Whitehouse ... to refit the entire space specifically for package testing. ...
(Date:9/17/2014)... Sept. 17, 2014 The global consumption of squalene ... Squalene is a natural skin-identical chemical that finds applications in ... food supplements, pharmaceuticals, and in other applications like high grade ... has a few major players and is regionally segregated. Sophim ... Liver Oil Co. Ltd. ( Japan ), SeaDragon ...
Breaking Biology Technology:Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3
... Sept. 28, 2011 ... a biopharmaceutical company developing and commercializing products targeting ... cancer, dermatology and drug delivery markets, today announced ... with HTI-501 (rHuCAT-L) in women with moderate to ...
... Calif., Sept. 28, 2011 Trimble (NASDAQ: ... of RFID patient safety solutions, has integrated the ThingMagic® ... XECAN solution enhances the patient experience and significantly assists ... organizations to offer a safer and more inviting medical ...
... at the University of Massachusetts Amherst report that for ... method of preparing ordered magnetic materials than ever before, ... temperatures. The innovative process allows them to ... periods more effectively and with fewer steps than more ...
Cached Biology Technology:Halozyme Begins Clinical Trial with HTI-501 in Women with Edematous Fibrosclerotic Panniculopathy 2Halozyme Begins Clinical Trial with HTI-501 in Women with Edematous Fibrosclerotic Panniculopathy 3XECAN and Trimble Partner to Deliver ThingMagic Powered RFID Oncology Solution 2XECAN and Trimble Partner to Deliver ThingMagic Powered RFID Oncology Solution 3XECAN and Trimble Partner to Deliver ThingMagic Powered RFID Oncology Solution 4XECAN and Trimble Partner to Deliver ThingMagic Powered RFID Oncology Solution 5New nanostructure-based process will streamline production of magnetic materials 2New nanostructure-based process will streamline production of magnetic materials 3
(Date:9/17/2014)... [Brown University] After decades of decline, grasses have ... To the eye, the marsh in those places seems ... a key service of the marsh coastal protection ... but the ecosystem function hasn,t come back," said ecologist ... author of the study in the journal Biological ...
(Date:9/17/2014)... As the United Kingdom forms a new crime unit ... an uproar last year over horse meat being passed ... a technique for detecting meat adulteration. They describe their ... in ACS, Journal of Agricultural and Food Chemistry ... fraud is a major global economic problem. But they ...
(Date:9/17/2014)... Transmission of bacterial infections, including MRSA and MSSA ... microscopic bumps that mimic the scaly surface of ... open access journal Antimicrobial Resistance and Infection ... different materials prevented the spread of human disease ... named Sharklet, is an arrangement of ridges formulated ...
Breaking Biology News(10 mins):Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3Sharks' skin has teeth in the fight against hospital superbugs 2
... little doctors could do to help a patient with advanced-stage ... discoveries about the deadly skin cancer. "I,ve been ... measure the most exciting time for melanoma research," said Brian ... Dermatology and Cutaneous Sciences at Michigan State University,s College of ...
... of the avian H7N9 influenza that emerged in China this ... to treat the infection, but testing for antiviral resistance can ... The authors of a study published in ... for Microbiology, characterized viruses taken from the first person known ...
... sea turtles in the northern Gulf of Mexico can ... offshore habitats between nesting events in a single season, ... industries. Evidence from a U.S. Geological Survey study ... one beach throughout the nesting season and suggests the ...
Cached Biology News:Tide is turning in skin cancer battle 2H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance 2H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance 3Nesting Gulf loggerheads face offshore risks 2Nesting Gulf loggerheads face offshore risks 3
... cDNA normalization is essential for hunting ... high-throughput approaches, such as EST sequencing ... normalization methods are not well suited ... The Evrogen TRIMMER kit, though, is ...
... Application: The Panorama Mouse/Rat Tissue Extract ... protein expression in various tissue extracts. The ... is detected using a protein specific antibody. ... binding is visualized by a sensitive chemiluminescent ...
... StabilGuard Choice Microsphere/Microarray Stabilizer is a ... Plus Stabilizer. This product is an ... a PBS buffer (phosphate buffered saline), pH ... a combination of 0.02% methylisothiazolone and 0.02% ...
... an aqueous-based mounting medium designed for ... Gel/Mount is especially recommended when using ... FluoroBlue. It can also be used ... fluorescein (FITC), Rhodamine (TMRITC) and Texas ...
Biology Products: